Aesthetic Injectables | Medtech 360 | Market Insights | Europe

Publish date: December 2018

Login to access report

The European aesthetic injectables market will grow rapidly through 2027, driven by increasing penetration into new patient groups, such as men and younger patients, as well as strong marketing efforts by major players in the aesthetics space. Nevertheless, as the market matures and price competition increases, market growth will decelerate to some extent.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for aesthetic injectables in Europe across a 10-year period.


Asian companies are looking to enter the European BTX and dermal filler markets. 

What strategies will South Korean and Chinese companies adopt to enter Europe?

Which partnerships are most notable in this market and what competitive advantages have they provided to the companies involved?

More number of plastic surgeons are performing aesthetic injectable procedures.

What is making aesthetic injectables popular amongst physicians?

Which all physicians can perform these procedures?

What are the new avenues for performing these procedures?

Intense competition is forcing new entrants as well as existing competitors to invest in R&D and innovation in order to differentiate their products.

What sort of product enhancements are being introduced, and why? 

What opportunities exist to expand the use of aesthetic injectables for nonfacial procedures?

Table of contents

  • Europe
    • Abstract
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • End-User Insights
      • Geographies Covered
      • Procedures and Products Covered
    • Version History
    • Aesthetic Injectable Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Improvements and Innovations
        • Physician Training and Marketing
        • First-Mover Advantage
        • Product Portfolio Management
        • Mergers, Acquisitions, and Partnerships
        • Clinical Data
        • Patient Marketing and Awareness
      • Market Developments
    • Botulinum Toxin Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Improvements and Innovations
        • Mergers, Acquisitions, and Partnerships
    • Dermal Filler Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Facial
        • Nonfacial
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Improvements and Innovations
        • Product Portfolio Management
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Raghav Tangri, MRes

Raghav Tangri is an analyst within the Endoscopy and Aesthetics Medtech Insights team at Decision Resources Group, specializing in facial injectables, hernia repair, and open surgery device markets; he has been featured in the Aesthetics Journal and has participated in several white papers and medtech blogs, with a specific focus on the Indian medical device industry. Raghav holds a Bachelor's degree in Biotechnology from Delhi Technological University and a Master's degree in Life Sciences from Imperial College London.